Mignon L. Loh mainly focuses on Cancer research, Leukemia, Immunology, Internal medicine and Mutation. Her research in Cancer research intersects with topics in Tyrosine kinase, STAT5, Philadelphia chromosome, Neuroblastoma RAS viral oncogene homolog and Juvenile myelomonocytic leukemia. Her Leukemia research includes themes of Missense mutation, Chronic myelomonocytic leukemia, Transplantation and Candidate gene.
Her Internal medicine study integrates concerns from other disciplines, such as Oncology and Genotype. Her Mutation study combines topics in areas such as Molecular biology and Janus kinase. Her Myeloid leukemia study incorporates themes from DNA microarray, Microarray databases, Significance analysis of microarrays and Bioinformatics.
Her primary areas of study are Internal medicine, Oncology, Cancer research, Leukemia and Immunology. Her Minimal residual disease, Acute lymphocytic leukemia, Chemotherapy and Lymphoblastic Leukemia study in the realm of Internal medicine interacts with subjects such as Cog. Her Acute lymphocytic leukemia research focuses on Vincristine and how it connects with Gastroenterology.
Her studies deal with areas such as Cancer, Hematopoietic stem cell transplantation, Clinical trial, Methotrexate and Young adult as well as Oncology. Her studies deal with areas such as Mutation, Juvenile myelomonocytic leukemia, Neuroblastoma RAS viral oncogene homolog and PTPN11 as well as Cancer research. Mignon L. Loh interconnects Molecular biology, Myeloid leukemia and Bone marrow in the investigation of issues within Leukemia.
Her main research concerns Internal medicine, Oncology, Leukemia, Lymphoblastic Leukemia and Cancer research. Her work on Hematopoietic stem cell transplantation, Young adult, Minimal residual disease and B lymphoblastic leukemia as part of general Internal medicine study is frequently connected to Cog, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her Oncology research is multidisciplinary, incorporating elements of Clinical trial, Refractory, Standard Risk, Chemotherapy and Cohort.
Her Leukemia study incorporates themes from Cancer, Haematopoiesis and Myeloid leukemia. Her Myeloid leukemia study which covers Childhood leukemia that intersects with Germline. Mignon L. Loh does research in Cancer research, focusing on Myeloid specifically.
Mignon L. Loh mainly investigates Internal medicine, Oncology, Cancer research, Lymphoblastic Leukemia and Genetics. Her Oncology research includes elements of Young adult, Clinical trial, Refractory and Chemotherapy. Her Cancer research research is multidisciplinary, relying on both RNA, Cell, Leukemia and In vivo.
Her Leukemia course of study focuses on Haematopoiesis and Tumor initiation, Progenitor cell and Lymphoblast. Her Asparaginase study in the realm of Lymphoblastic Leukemia connects with subjects such as Extramural. Her Cohort study deals with Acute leukemia intersecting with Myeloid leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.
T. R. Golub;T. R. Golub;D. K. Slonim;P. Tamayo;C. Huard.
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang;Li Ding;Linda Holmfeldt;Gang Wu.
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
Adolfo A Ferrando;Donna S Neuberg;Jane Staunton;Mignon L Loh.
Cancer Cell (2002)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts;Y. Li;D. Payne-Turner;R. C. Harvey.
The New England Journal of Medicine (2014)
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia
W.-J. Song;M. G. Sullivan;R. D. Legare;S. Hutchings.
Nature Genetics (1999)
Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia
Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst.
Cancer Cell (2012)
JAK mutations in high-risk childhood acute lymphoblastic leukemia.
Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood.
Proceedings of the National Academy of Sciences of the United States of America (2009)
The genomic landscape of hypodiploid acute lymphoblastic leukemia
Linda Holmfeldt;Lei Wei;Ernesto Diaz-Flores;Michael Walsh.
Nature Genetics (2013)
An Oncogenic Super-Enhancer Formed Through Somatic Mutation of a Noncoding Intergenic Element
Marc R. Mansour;Marc R. Mansour;Brian J. Abraham;Lars Anders;Alla Berezovskaya.
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
Yu Liu;John Easton;Ying Shao;Jamie Maciaszek.
Nature Genetics (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: